Osteoporosis
From the Journals
Bone density gains are lost following stop of denosumab in glucocorticoid-treated RA
When denosumab is discontinued, glucocorticoid-treated patients with rheumatoid arthritis need to transition to another osteoporosis therapy.
Guidelines
Menopause society issues first osteoporosis advice in 10 years
In the first update since 2010, the North American Menopause Society addresses new advances, including use of novel agents to prevent “bone...
From the Journals
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
From the Journals
Osteoporosis linked to increased risk of hearing loss
Moderate to severe hearing loss was independently associated with osteoporosis, vertebral fracture in the large, longitudinal Nurses’ Health Study...
From the Journals
Any bone break increases risk for subsequent fracture in older women
Although most guidelines warn of subsequent fracture risk after hip and spine fractures, the increased risk is seen in a multitude of other bone...
Guidelines
Don’t screen for vitamin D in general population, says USPSTF
There is insufficient evidence that screening for vitamin D deficiency among the asymptomatic general population is of any benefit, concludes an...
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
Conference Coverage
Denosumab now dominant therapy for osteoporosis linked to cancer
In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.
From the Journals
Abdominal aortic calcification may further raise known fracture risk
Men with a prevalent vertebral fracture on lateral spine radiograph had even greater risk for future osteoporotic fractures with increasing...
Guidelines
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
From the Journals
Bone loss common in kidney stone patients, yet rarely detected
Almost one-quarter of patients diagnosed with kidney stones have osteoporosis or a fracture history on diagnosis, yet few undergo bone mineral...